Home
NICE Guidance
NICE Advice
Evidence summaries

Chronic obstructive pulmonary disease: fluticasone furoate, umeclidinium and vilanterol (Trelegy)

Evidence summary [ES18] Published: 14 June 2018 Last updated: 15 December 2021

Advice

This evidence summary has been updated and replaced by NICE guideline 115.